An interventional study of Neural Mobilization and Sham Neural Mobilization in Herniated Disc and Sciatica Due to Intervertebral Disc Disorder, sponsored by Longhua Hospital. Completed at 1 site in China. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-08-07.
Sponsored by Longhua Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 52 studies in Intervertebral Disc Displacement with a site in China — 13 open to participants now, 14 under way, none of them phase 3. Intervertebral Disc Displacement · China.
Among the 52 studies in Intervertebral Disc Displacement with a site in China, this one is the 30th largest by enrollment of the 41 interventional ones that give a count, is one of 6 that started in 2025, is one of 35 with no phase, and was the 47th registered.
474 studies on the registry are indexed under Intervertebral Disc Displacement; 99 are open to participants now.
Browse Intervertebral Disc Displacement studies →13 of the 52 studies in Intervertebral Disc Displacement with a site in China are open now. Recruiting first, the newest first:
Fan Zhang · Sites in China
Ages 18–75
The Affiliated Hospital of Qingdao University · Sites in China
Ages 12–65
Li Xiang · Sites in China
Ages 19–65
Peking University Third Hospital · Sites in China
Ages 18–80
The Third Affiliated hospital of Zhejiang Chinese Medical University · Sites in China
Ages 20–60 · Healthy volunteers
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 49 Intervertebral Disc Displacement studies recruiting now, 20 (41%) set no upper age limit and 25 (51%) stop at 75 or younger; 3 take children under 18; 6 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
52 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 6 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 72 is above the median of 63 across 344 interventional studies indexed under Intervertebral Disc Displacement.
Median enrollment 90 across the 41 interventional studies, 120 across the 11 observational. Of the 19 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 52 has an industry lead sponsor. The 10 most frequent:
Longhua Hospital is the lead sponsor of 4 studies on the registry; 2 are open to participants now.
Longhua Hospital has 1 study filed under Intervertebral Disc Displacement — fewer than ten, so there is no comparison to draw.
5 of the studies in Intervertebral Disc Displacement with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07161232Li XiangThe Influence of the Timing of Postoperative Rehabilitation Intervention on the Clinical Efficacy of Unilateral Biportal Endoscopic Spine System in the Treatment of Lumbar Disc Herniation | 2026-11-28 |
| NCT07531485Xi'an Honghui HospitalThe Selective Intraperineural Nerve Root Block Study | 2026-12-01 |
| NCT07250581The Affiliated Hospital of Qingdao UniversityA Randomized Trial of Annular Repair With Discectomy Versus Discectomy Alone for Lumbar Disc Herniation | 2026-12-31 |
| NCT07728149The Third Affiliated hospital of Zhejiang Chinese Medical UniversityBrain Connectomic Mechanisms of Spinal Manipulative Therapy on LDH Analgesia Based on Multimodal MRI | 2027-09 |
| NCT06591442Wuhan Union Hospital, ChinaScreening and Prospective Cohort Study of Risk Factors for Enhanced Recovery After Spinal Fusion Surgery in Advanced Age Patient | 2027-09-03 |
Add all 5 to your calendar (.ics) → With an account.
Among the 52 studies in Intervertebral Disc Displacement with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The objective of this randomized controlled clinical trial is to evaluate whether manual therapy combined with neural mobilization can improve pain, functional impairment, quality of life, inflammatory markers, and infrared thermographic findings in patients with lumbar disc herniation. The study subjects consist of 72 patients with lumbar disc herniation (aged 18-65 years, with unilateral lumbar radicular symptoms).
The primary questions it aims to address are:
The researchers compared:
to determine whether adding neural mobilization can provide additional therapeutic effects, including better pain relief, functional recovery, and improvement in related physiological indicators.
Participants will:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
-
Participants will be eligible for inclusion if they meet the following criteria:
Adults aged 18-65 years. Diagnosis of lumbar disc herniation based on clinical symptoms and imaging findings.
Presence of unilateral lumbar radiculopathy. Persistent symptoms despite initial conservative management. Ability to participate in the intervention protocol. Provided written before study enrollment.
Exclusion Criteria:
-
Participants will be excluded if they meet any of the following criteria:
Requirement for surgical intervention for lumbar disc herniation. Serious spinal conditions, including spinal infection, tumor, or fracture. Severe systemic diseases or acute inflammatory conditions. Pregnancy or breastfeeding. Receipt of other interventions that may affect study outcomes during the study period.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Manual Therapy + Neural Mobilization
Behavioral: Neural Mobilization · Behavioral: Manual Therapy
Manual Therapy + Sham Neural Mobilization
Behavioral: Sham Neural Mobilization · Behavioral: Manual Therapy
Neural mobilization will be performed using neurodynamics techniques, aiming to improve neural activity and reduce neural mechanosensitivity. The intervention will be conducted over a period of three weeks.
The posture and duration of pseudo neural stretching therapy do not produce the expected neurodynamic effects.
Participants in both groups will receive standardized manual therapy targeting the lumbar spine. The intervention includes lumbar posterior-to-anterior (PA) mobilization and soft tissue mobilization techniques applied to the lumbar paraspinal muscles, gluteal muscles, piriformis, and proximal hamstrings. Manual therapy will be performed within a tolerable range without provoking symptom exacerbation and will be administered every other day for 3 weeks (a total of 11 sessions).
Change in Oswestry Disability Index (ODI) Score
Time frame: Baseline and Week 3 (end of intervention)
Change in Pain Intensity Measured by Visual Analog Scale (VAS)
Time frame: Baseline and Week 3 (end of intervention)
Health-related quality of life (SF-12)
Time frame: Baseline and Week 3
Change in Infrared Thermographic Temperature Parameters
Time frame: Baseline, Week 1, and Week 3
Change in Serum Inflammatory Biomarkers (IL-6 and TNF-α)
Time frame: Baseline and Week 3
Plan to share: No
Ran from Apr 2025 to primary completion in Dec 2025, 8 months.
Of 178 non-industry interventional studies with no phase under Intervertebral Disc Displacement, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 23. This study's 8 months is below that.
Counting every sponsor, half of 191 studies reached it within 12 months; a quarter within 5 and three quarters within 27.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Intervertebral Disc Displacement →
Longhua Hospital